モレキュラーデバイスジャパン 東京本社 Official site

Flexibly enhancing the compliance of plate readers from research to GMP.

From research to GMP, strengthen compliance in line with the growth of the lab and ensure data integrity.

SoftMax Pro GxP software controls plate readers and performs data analysis, providing a flexible compliance environment that meets current management needs and future GMP compliance. Many labs do not need to fully meet GMP requirements from the start. They begin with drug discovery and development, where scientific flexibility is prioritized, and gradually add necessary management functions as they progress to clinical development, QC release testing, and commercial manufacturing. It is often thought that transitioning to a more stringent regulatory environment requires a software overhaul. However, it can be consistently managed across a single scalable platform from research and drug discovery to development, validation, and commercialization. By enhancing compliance management according to regulatory requirements, users can continue to use the familiar SoftMax Pro while adding the governance, data integrity, security, and audit functions necessary for GMP operations. This minimizes the impact on existing operations and reduces the burden of validation while maintaining user proficiency. It allows for a smooth transition from a research/GLP environment to a GMP-compliant manufacturing and quality control environment.

Related Link - https://www.moleculardevices.co.jp/products/microp…

basic information

https://www.moleculardevices.co.jp/products/microplate-readers/software/softmax-pro-7software.html#anc05

Price information

Please contact us.

Delivery Time

Applications/Examples of results

Microplate reader control analysis

SoftMax Pro GxP Compliance Guide

TECHNICAL

SoftMax Pro 7.6 Product Data Sheet

OTHER

Recommended products

Distributors

Molecular Devices Japan, Inc. is a leading global provider of high-performance bioanalytical measurement systems, software, and consumables for life science research, drug development, and biotherapeutics, including microplate readers and imaging systems. We are committed to the continuous development of innovative solutions for life science applications.